Mawer Investment Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-323,310
Closed -$2.47M 108
2023
Q3
$2.47M Buy
323,310
+25,159
+8% +$189K 0.01% 93
2023
Q2
$2.15M Buy
298,151
+23,920
+9% +$139K 0.01% 93
2023
Q1
$1.67M Buy
274,231
+1,757
+0.6% +$9.52K 0.01% 97
2022
Q4
$1.19M Sell
272,474
-46,467
-15% -$208K 0.01% 103
2022
Q3
$1.25M Buy
318,941
+46,306
+17% +$232K 0.01% 95
2022
Q2
$1.39M Buy
272,635
+63,888
+31% +$332K 0.01% 85
2022
Q1
$1.34M Buy
208,747
+123,232
+144% +$817K 0.01% 89
2021
Q4
$686K Buy
85,515
+63,120
+282% +$595K ﹤0.01% 106
2021
Q3
$207K Buy
+22,395
New +$234K ﹤0.01% 108

Other funds holding CLBT